nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Bleomycin—testicular cancer	0.0814	0.0814	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Ifosfamide—testicular cancer	0.0696	0.0696	CcSEcCtD
Clavulanate—Induration—Bleomycin—testicular cancer	0.0365	0.0365	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Epirubicin—testicular cancer	0.0308	0.0308	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Doxorubicin—testicular cancer	0.0285	0.0285	CcSEcCtD
Clavulanate—Induration—Etoposide—testicular cancer	0.0247	0.0247	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Chlorambucil—testicular cancer	0.0138	0.0138	CcSEcCtD
Clavulanate—Pain—Carboplatin—testicular cancer	0.0125	0.0125	CcSEcCtD
Clavulanate—Thrombophlebitis—Ifosfamide—testicular cancer	0.0117	0.0117	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Chlorambucil—testicular cancer	0.0117	0.0117	CcSEcCtD
Clavulanate—Swelling—Ifosfamide—testicular cancer	0.0115	0.0115	CcSEcCtD
Clavulanate—Erythema multiforme—Chlorambucil—testicular cancer	0.01	0.01	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Dactinomycin—testicular cancer	0.00996	0.00996	CcSEcCtD
Clavulanate—Haemoglobin—Vinblastine—testicular cancer	0.00976	0.00976	CcSEcCtD
Clavulanate—Haemorrhage—Vinblastine—testicular cancer	0.00971	0.00971	CcSEcCtD
Clavulanate—Hypokalaemia—Ifosfamide—testicular cancer	0.00922	0.00922	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Ifosfamide—testicular cancer	0.00913	0.00913	CcSEcCtD
Clavulanate—Swelling—Etoposide—testicular cancer	0.00907	0.00907	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.00845	0.00845	CcSEcCtD
Clavulanate—Leukopenia—Chlorambucil—testicular cancer	0.00826	0.00826	CcSEcCtD
Clavulanate—Haemoglobin—Bleomycin—testicular cancer	0.00825	0.00825	CcSEcCtD
Clavulanate—Haemorrhage—Bleomycin—testicular cancer	0.0082	0.0082	CcSEcCtD
Clavulanate—Convulsion—Chlorambucil—testicular cancer	0.008	0.008	CcSEcCtD
Clavulanate—Hypokalaemia—Cisplatin—testicular cancer	0.00795	0.00795	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.00774	0.00774	CcSEcCtD
Clavulanate—Hepatitis—Dactinomycin—testicular cancer	0.00765	0.00765	CcSEcCtD
Clavulanate—Leukopenia—Vinblastine—testicular cancer	0.00757	0.00757	CcSEcCtD
Clavulanate—Thrombocytopenia—Chlorambucil—testicular cancer	0.00737	0.00737	CcSEcCtD
Clavulanate—Convulsion—Vinblastine—testicular cancer	0.00733	0.00733	CcSEcCtD
Clavulanate—Erythema multiforme—Dactinomycin—testicular cancer	0.00723	0.00723	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.00721	0.00721	CcSEcCtD
Clavulanate—Haemoglobin—Ifosfamide—testicular cancer	0.00705	0.00705	CcSEcCtD
Clavulanate—Jaundice cholestatic—Epirubicin—testicular cancer	0.00704	0.00704	CcSEcCtD
Clavulanate—Haemorrhage—Ifosfamide—testicular cancer	0.00701	0.00701	CcSEcCtD
Clavulanate—Hepatitis—Ifosfamide—testicular cancer	0.00701	0.00701	CcSEcCtD
Clavulanate—Thrombocytopenia—Vinblastine—testicular cancer	0.00676	0.00676	CcSEcCtD
Clavulanate—Erythema multiforme—Ifosfamide—testicular cancer	0.00663	0.00663	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00651	0.00651	CcSEcCtD
Clavulanate—Pain—Chlorambucil—testicular cancer	0.00644	0.00644	CcSEcCtD
Clavulanate—Leukopenia—Bleomycin—testicular cancer	0.00639	0.00639	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00612	0.00612	CcSEcCtD
Clavulanate—Urticaria—Chlorambucil—testicular cancer	0.00598	0.00598	CcSEcCtD
Clavulanate—Leukopenia—Dactinomycin—testicular cancer	0.00596	0.00596	CcSEcCtD
Clavulanate—Pain—Vinblastine—testicular cancer	0.0059	0.0059	CcSEcCtD
Clavulanate—Anaphylactic shock—Bleomycin—testicular cancer	0.00583	0.00583	CcSEcCtD
Clavulanate—Thrombocytopenia—Bleomycin—testicular cancer	0.00571	0.00571	CcSEcCtD
Clavulanate—Hypersensitivity—Chlorambucil—testicular cancer	0.00555	0.00555	CcSEcCtD
Clavulanate—Thrombophlebitis—Methotrexate—testicular cancer	0.00554	0.00554	CcSEcCtD
Clavulanate—Leukopenia—Ifosfamide—testicular cancer	0.00546	0.00546	CcSEcCtD
Clavulanate—Pruritus—Chlorambucil—testicular cancer	0.00533	0.00533	CcSEcCtD
Clavulanate—Thrombocytopenia—Dactinomycin—testicular cancer	0.00532	0.00532	CcSEcCtD
Clavulanate—Convulsion—Ifosfamide—testicular cancer	0.00529	0.00529	CcSEcCtD
Clavulanate—Erythema multiforme—Etoposide—testicular cancer	0.00524	0.00524	CcSEcCtD
Clavulanate—Thrombophlebitis—Epirubicin—testicular cancer	0.00518	0.00518	CcSEcCtD
Clavulanate—Diarrhoea—Chlorambucil—testicular cancer	0.00515	0.00515	CcSEcCtD
Clavulanate—Hypersensitivity—Vinblastine—testicular cancer	0.00508	0.00508	CcSEcCtD
Clavulanate—Pain—Bleomycin—testicular cancer	0.00498	0.00498	CcSEcCtD
Clavulanate—Anaphylactic shock—Ifosfamide—testicular cancer	0.00498	0.00498	CcSEcCtD
Clavulanate—Thrombocytopenia—Ifosfamide—testicular cancer	0.00488	0.00488	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—testicular cancer	0.0048	0.0048	CcSEcCtD
Clavulanate—Vomiting—Chlorambucil—testicular cancer	0.00479	0.00479	CcSEcCtD
Clavulanate—Diarrhoea—Vinblastine—testicular cancer	0.00472	0.00472	CcSEcCtD
Clavulanate—Leukopenia—Cisplatin—testicular cancer	0.00471	0.00471	CcSEcCtD
Clavulanate—Pain—Dactinomycin—testicular cancer	0.00465	0.00465	CcSEcCtD
Clavulanate—Urticaria—Bleomycin—testicular cancer	0.00463	0.00463	CcSEcCtD
Clavulanate—Convulsion—Cisplatin—testicular cancer	0.00456	0.00456	CcSEcCtD
Clavulanate—Nausea—Chlorambucil—testicular cancer	0.00447	0.00447	CcSEcCtD
Clavulanate—Vomiting—Vinblastine—testicular cancer	0.00439	0.00439	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00432	0.00432	CcSEcCtD
Clavulanate—Leukopenia—Etoposide—testicular cancer	0.00432	0.00432	CcSEcCtD
Clavulanate—Anaphylactic shock—Cisplatin—testicular cancer	0.00429	0.00429	CcSEcCtD
Clavulanate—Hypersensitivity—Bleomycin—testicular cancer	0.00429	0.00429	CcSEcCtD
Clavulanate—Pain—Ifosfamide—testicular cancer	0.00426	0.00426	CcSEcCtD
Clavulanate—Thrombocytopenia—Cisplatin—testicular cancer	0.00421	0.00421	CcSEcCtD
Clavulanate—Convulsion—Etoposide—testicular cancer	0.00418	0.00418	CcSEcCtD
Clavulanate—Pruritus—Bleomycin—testicular cancer	0.00412	0.00412	CcSEcCtD
Clavulanate—Eosinophilia—Methotrexate—testicular cancer	0.0041	0.0041	CcSEcCtD
Clavulanate—Nausea—Vinblastine—testicular cancer	0.0041	0.0041	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—testicular cancer	0.00408	0.00408	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00404	0.00404	CcSEcCtD
Clavulanate—Hypersensitivity—Dactinomycin—testicular cancer	0.00401	0.00401	CcSEcCtD
Clavulanate—Urticaria—Ifosfamide—testicular cancer	0.00396	0.00396	CcSEcCtD
Clavulanate—Anaphylactic shock—Etoposide—testicular cancer	0.00393	0.00393	CcSEcCtD
Clavulanate—Thrombocytopenia—Etoposide—testicular cancer	0.00385	0.00385	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—testicular cancer	0.00384	0.00384	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—testicular cancer	0.00378	0.00378	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00374	0.00374	CcSEcCtD
Clavulanate—Diarrhoea—Dactinomycin—testicular cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Vomiting—Bleomycin—testicular cancer	0.00371	0.00371	CcSEcCtD
Clavulanate—Rash—Bleomycin—testicular cancer	0.00368	0.00368	CcSEcCtD
Clavulanate—Pain—Cisplatin—testicular cancer	0.00367	0.00367	CcSEcCtD
Clavulanate—Dermatitis—Bleomycin—testicular cancer	0.00367	0.00367	CcSEcCtD
Clavulanate—Hypersensitivity—Ifosfamide—testicular cancer	0.00367	0.00367	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00366	0.00366	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—testicular cancer	0.00355	0.00355	CcSEcCtD
Clavulanate—Pruritus—Ifosfamide—testicular cancer	0.00352	0.00352	CcSEcCtD
Clavulanate—Nausea—Bleomycin—testicular cancer	0.00346	0.00346	CcSEcCtD
Clavulanate—Vomiting—Dactinomycin—testicular cancer	0.00346	0.00346	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00343	0.00343	CcSEcCtD
Clavulanate—Rash—Dactinomycin—testicular cancer	0.00343	0.00343	CcSEcCtD
Clavulanate—Diarrhoea—Ifosfamide—testicular cancer	0.00341	0.00341	CcSEcCtD
Clavulanate—Pain—Etoposide—testicular cancer	0.00336	0.00336	CcSEcCtD
Clavulanate—Haemoglobin—Methotrexate—testicular cancer	0.00333	0.00333	CcSEcCtD
Clavulanate—Hepatitis—Methotrexate—testicular cancer	0.00332	0.00332	CcSEcCtD
Clavulanate—Haemorrhage—Methotrexate—testicular cancer	0.00332	0.00332	CcSEcCtD
Clavulanate—Nausea—Dactinomycin—testicular cancer	0.00323	0.00323	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00317	0.00317	CcSEcCtD
Clavulanate—Vomiting—Ifosfamide—testicular cancer	0.00317	0.00317	CcSEcCtD
Clavulanate—Hypersensitivity—Cisplatin—testicular cancer	0.00316	0.00316	CcSEcCtD
Clavulanate—Rash—Ifosfamide—testicular cancer	0.00314	0.00314	CcSEcCtD
Clavulanate—Dermatitis—Ifosfamide—testicular cancer	0.00314	0.00314	CcSEcCtD
Clavulanate—Erythema multiforme—Methotrexate—testicular cancer	0.00314	0.00314	CcSEcCtD
Clavulanate—Urticaria—Etoposide—testicular cancer	0.00313	0.00313	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—testicular cancer	0.00312	0.00312	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Clavulanate—Nausea—Ifosfamide—testicular cancer	0.00296	0.00296	CcSEcCtD
Clavulanate—Diarrhoea—Cisplatin—testicular cancer	0.00294	0.00294	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—testicular cancer	0.00294	0.00294	CcSEcCtD
Clavulanate—Hypersensitivity—Etoposide—testicular cancer	0.0029	0.0029	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—testicular cancer	0.00289	0.00289	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—testicular cancer	0.00287	0.00287	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—testicular cancer	0.00287	0.00287	CcSEcCtD
Clavulanate—Pruritus—Etoposide—testicular cancer	0.00278	0.00278	CcSEcCtD
Clavulanate—Vomiting—Cisplatin—testicular cancer	0.00273	0.00273	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Clavulanate—Rash—Cisplatin—testicular cancer	0.00271	0.00271	CcSEcCtD
Clavulanate—Dermatitis—Cisplatin—testicular cancer	0.00271	0.00271	CcSEcCtD
Clavulanate—Diarrhoea—Etoposide—testicular cancer	0.00269	0.00269	CcSEcCtD
Clavulanate—Leukopenia—Methotrexate—testicular cancer	0.00258	0.00258	CcSEcCtD
Clavulanate—Nausea—Cisplatin—testicular cancer	0.00255	0.00255	CcSEcCtD
Clavulanate—Convulsion—Methotrexate—testicular cancer	0.0025	0.0025	CcSEcCtD
Clavulanate—Vomiting—Etoposide—testicular cancer	0.0025	0.0025	CcSEcCtD
Clavulanate—Rash—Etoposide—testicular cancer	0.00248	0.00248	CcSEcCtD
Clavulanate—Dermatitis—Etoposide—testicular cancer	0.00248	0.00248	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Clavulanate—Anaphylactic shock—Methotrexate—testicular cancer	0.00236	0.00236	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—testicular cancer	0.00234	0.00234	CcSEcCtD
Clavulanate—Nausea—Etoposide—testicular cancer	0.00234	0.00234	CcSEcCtD
Clavulanate—Thrombocytopenia—Methotrexate—testicular cancer	0.00231	0.00231	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Clavulanate—Pain—Methotrexate—testicular cancer	0.00202	0.00202	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Clavulanate—Pain—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Clavulanate—Urticaria—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Clavulanate—Pain—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Clavulanate—Hypersensitivity—Methotrexate—testicular cancer	0.00174	0.00174	CcSEcCtD
Clavulanate—Pruritus—Methotrexate—testicular cancer	0.00167	0.00167	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Clavulanate—Diarrhoea—Methotrexate—testicular cancer	0.00161	0.00161	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Clavulanate—Vomiting—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Clavulanate—Rash—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Clavulanate—Dermatitis—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Nausea—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Rash—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Clavulanate—Nausea—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Clavulanate—Rash—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
